Trials / Recruiting
RecruitingNCT07110285
Ovarian Stimulation Outcomes During a GnRH Antagonist Protocol for In-vitro Fertilization When Comparing Trigger Day Decision by Physicians Versus an Artificial Intelligence-based Algorithm.
Ovarian Stimulation Outcomes During a GnRH Antagonist Protocol for In-vitro Fertilization When Comparing Trigger Day Decision by Physicians Versus an Artificial Intelligence-based Algorithm - A Randomized Control Study.
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 180 (estimated)
- Sponsor
- FertilAI · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
To compare the number of mature oocytes following a GnRH antagonist in-vitro fertilization stimulation cycle when comparing trigger day timing decision by physicians versus an artificial intelligence-based algorithm
Detailed description
Examination of all patients undergoing an ovarian stimulation cycle utilizing the GnRH antagonist protocol for oocyte cryopreservation or for fertilization via intracytoplasmic sperm injection (ICSI) (any treatment where oocytes are denuded and maturity may be assessed). The number of mature oocytes will be compared between cycles where trigger day timing was decided by the treating physician versus an artificial intelligence-based algorithm.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Artificial intelligence-based algorithm | Trigger day timing decision by an artificial intelligence-based algorithm |
Timeline
- Start date
- 2025-05-21
- Primary completion
- 2027-05-01
- Completion
- 2028-05-21
- First posted
- 2025-08-07
- Last updated
- 2026-01-12
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT07110285. Inclusion in this directory is not an endorsement.